|
End-of-day quote
Shanghai S.E.
16/11/2026
|
5-day change | 1st Jan Change | ||
| 14.39 CNY | +2.93% |
|
+0.70% | -4.51% |
| 10-26 | Citi Adjusts Tasly Pharmaceutical Group's Price Target to 16.50 Yuan | MT |
| 10-15 | Huachuang Securities Starts Tasly Pharmaceutical Group at Add with 17.20 Yuan Price Target | MT |
| Market Cap | 21.5B 3.22B 2.93B 2.71B 2.44B 4.61B 303B 4.78B 32.55B 12.9B 162B 12.1B 11.84B 515B | P/E 2026 * |
16.6x | P/E 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise Value | 19.67B 2.95B 2.68B 2.48B 2.24B 4.22B 277B 4.37B 29.79B 11.8B 149B 11.07B 10.84B 471B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 1.72x |
| Free-Float |
47.06% | Yield 2026 * |
2.56% | Yield 2027 * | 3.07% |
| 1 day | +2.93% | ||
| 1 week | +0.70% | ||
| Current month | +4.12% | ||
| 1 month | +2.49% | ||
| 3 months | -6.13% | ||
| 6 months | -1.71% | ||
| Current year | -4.51% |
| 1 week | 13.77 | 14.52 | |
| 1 month | 13.48 | 14.59 | |
| Current year | 12.9 | 16.24 | |
| 1 year | 12.9 | 16.24 | |
| 3 years | 12.24 | 18 | |
| 5 years | 9.2 | 18 | |
| 10 years | 9.2 | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 07/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 08/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 30/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 01/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 09/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 59 | 07/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.93% | +0.70% | -8.46% | -1.98% | 3.22B | ||
| -0.82% | +1.40% | +39.64% | +143.17% | 1,275B | ||
| -1.12% | +0.16% | +44.21% | +88.24% | 680B | ||
| -0.16% | +0.43% | +26.76% | +113.01% | 521B | ||
| -0.56% | +1.47% | +41.96% | +71.59% | 389B | ||
| -2.23% | -2.89% | +55.47% | +41.64% | 356B | ||
| -0.77% | +0.25% | +27.45% | +60.31% | 305B | ||
| -0.98% | +0.13% | +2.28% | +35.50% | 287B | ||
| -0.72% | -0.63% | +37.29% | +71.87% | 250B | ||
| -0.30% | -1.03% | +34.04% | +124.88% | 208B | ||
| Average | -0.47% | +0.62% | +30.06% | +74.82% | 428B | |
| Weighted average by Cap. | -0.86% | +0.76% | +36.50% | +97.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.52B 1.28B 1.16B 1.07B 969M 1.83B 120B 1.89B 12.9B 5.11B 64.39B 4.8B 4.69B 204B | 9.2B 1.38B 1.25B 1.16B 1.05B 1.97B 130B 2.04B 13.93B 5.52B 69.51B 5.18B 5.07B 220B |
| Net income | 1.29B 194M 176M 163M 147M 278M 18.23B 288M 1.96B 776M 9.78B 728M 713M 30.99B | 1.52B 229M 208M 192M 173M 327M 21.46B 339M 2.31B 914M 11.52B 858M 840M 36.48B |
| Net Debt | -1.82B -274M -249M -230M -208M -392M -25.7B -405M -2.76B -1.09B -13.79B -1.03B -1.01B -43.68B | -5.68B -851M -773M -715M -645M -1.22B -79.93B -1.26B -8.59B -3.4B -42.89B -3.19B -3.13B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | CN¥14.39 | +2.93% | 21,853,322 |
| 13/11/26 | CN¥13.98 | +0.14% | 10,524,160 |
| 12/11/26 | CN¥13.96 | -0.14% | 13,026,320 |
| 11/11/26 | CN¥13.98 | -1.27% | 9,529,058 |
| 10/11/26 | CN¥14.16 | -0.91% | 9,113,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
















